Cargando…
Inhaled corticosteroids improve lung function, airway hyper-responsiveness and airway inflammation but not symptom control in patients with mild intermittent asthma: A meta-analysis
It remains controversial whether inhaled corticosteroid (ICS) should be used in patients with intermittent asthma. The present study aimed to assess the effect of ICS compared with placebo or other therapies in patients with intermittent asthma. Medline, Embase and CNKI databases were searched up to...
Autores principales: | Du, Wei, Zhou, Ling, Ni, Yingmeng, Yu, Yuanyuan, Wu, Fang, Shi, Guochao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526093/ https://www.ncbi.nlm.nih.gov/pubmed/28810625 http://dx.doi.org/10.3892/etm.2017.4694 |
Ejemplares similares
-
Size of Inhaled Corticosteroid and Small Airway Inflammation in Asthma
por: Park, Choon-Sik
Publicado: (2017) -
Effect of inhaled corticosteroids on microbiome and microbial correlations in asthma over a 9‐month period
por: Huang, Chunrong, et al.
Publicado: (2022) -
The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids
por: Martin, Matthew J., et al.
Publicado: (2020) -
PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation
por: Du, Juan, et al.
Publicado: (2023) -
Effects of Corni fructus on ovalbumin-induced airway inflammation and airway hyper-responsiveness in a mouse model of allergic asthma
por: Kim, Seung-Hyung, et al.
Publicado: (2012)